Exact Sciences (EXAS) Misses Q3 EPS by 1c

Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.45), $0.01 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $12.56 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR1,700 at HSBC
• Deutsche Bank Starts Regal Rexnord Corp (RRX) at Buy